Mirum Pharmaceuticals, Inc. MIRM Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s interest expense?
- Mirum Pharmaceuticals, Inc. (MIRM) reported interest expense of $3.62M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s interest expense changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s interest expense increased by 0.6% year-over-year, from $3.6M to $3.62M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s interest expense?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s interest expense has grown at a -3.4% compound annual growth rate (CAGR), from $15.98M to $14.39M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.